Infrared Therapy for Inflammation: Mechanisms and Evidence
Near-infrared light reduces inflammation through specific molecular pathways. Far-infrared produces anti-inflammatory effects through heat stress. Here's what each does and where the evidence is strongest.
Two Infrared Wavelength Ranges, Two Anti-Inflammatory Mechanisms
Reducing inflammation through infrared exposure happens through fundamentally different pathways depending on which part of the infrared spectrum you're using.
Near-infrared (NIR, 700–1,100nm) acts through photobiomodulation: specific molecular interactions that alter gene expression, cytokine signaling, and cellular metabolism. The effects are photochemical and relatively independent of tissue heating.
Far-infrared (FIR, 5,000–15,000nm) works through thermal mechanisms: heat absorbed in superficial tissue raises local and eventually systemic temperature, which activates heat shock protein synthesis and alters inflammatory mediator profiles through temperature-dependent pathways.
Both reduce inflammation. They do it differently, the evidence supports different applications, and the clinical context determines which is more appropriate.
NIR: The Molecular Anti-Inflammatory Pathway
Near-infrared light at 810–850nm suppresses inflammatory signaling through several established mechanisms:
NF-kB inhibition. Nuclear factor kappa B (NF-kB) is the master transcription factor for inflammation. It controls the expression of dozens of pro-inflammatory genes including those encoding TNF-α, IL-1β, IL-6, and COX-2. Several studies have demonstrated that PBM reduces NF-kB activation in stimulated immune cells and inflamed tissue. Lower NF-kB activity means reduced downstream inflammatory gene expression.
Cytokine profile normalization. Published research shows PBM reduces TNF-α, IL-1β, and IL-6 while increasing anti-inflammatory cytokines including IL-10. These measurements have been made in animal models of arthritis, in vitro studies with stimulated macrophages, and in some human trials measuring systemic and local cytokine levels before and after treatment.
Reactive oxygen species modulation. Chronic inflammation involves dysregulated ROS production. PBM at appropriate doses normalizes ROS levels in inflamed tissue — reducing the excess that drives oxidative damage while maintaining the basal ROS signaling needed for normal cellular function. This is dose-dependent: appropriate doses normalize ROS; excessive doses can increase ROS.
Mitochondrial function in immune cells. Macrophages and neutrophils present at inflammatory sites have high energy demands. NIR-induced ATP increase supports their resolution functions (phagocytosis of cellular debris, secretion of resolution mediators) over their pro-inflammatory activation functions.
FIR: The Thermal Anti-Inflammatory Pathway
Far-infrared heating of tissue triggers heat shock protein (HSP) synthesis, particularly HSP70 and HSP90. Heat shock proteins are molecular chaperones — they repair unfolded or damaged proteins and play active roles in anti-inflammatory signaling.
HSP70 directly inhibits NF-kB activation and reduces the secretion of inflammatory cytokines from stimulated macrophages. Regular heat exposure (from sauna or FIR devices) that repeatedly induces HSP synthesis produces a sustained anti-inflammatory adaptation — the cells are primed for faster, more effective inflammation resolution.
Additionally, the increased circulation from heat-induced vasodilation accelerates the delivery of immune cells to inflamed tissue and the clearance of inflammatory mediators and cellular debris. This contributes to faster resolution of acute inflammation and reduced chronicity.
Rheumatoid Arthritis
RA involves autoimmune-driven joint inflammation with synovial proliferation, cartilage destruction, and systemic inflammatory burden. Both NIR and FIR have trial evidence in this population.
For FIR: Oosterveld et al. (2009) conducted a controlled study of infrared sauna in RA and ankylosing spondylitis patients. Eight-session courses of FIR sauna produced significant reductions in pain and stiffness scores, with good tolerability. The study was small (34 patients), but the signal was positive and no adverse events were observed.
For NIR: Multiple case series and small trials on LLLT applied to RA-affected joints show reduced joint tenderness, reduced inflammatory markers in synovial fluid, and decreased use of analgesics. A systematic review by Brosseau et al. for the Cochrane Musculoskeletal Group found low-level laser therapy for RA produced short-term reduction in pain and morning stiffness compared to placebo. Evidence quality was rated as moderate, limited by trial sizes.
Sports Injury and Exercise-Induced Inflammation
Exercise-induced muscle damage (EIMD) produces a predictable inflammatory response: neutrophil infiltration within hours, macrophage accumulation over days, elevated creatine kinase and lactate dehydrogenase in blood, and delayed onset muscle soreness (DOMS) peaking at 24–72 hours post-exercise.
Ferraresi et al.'s 2016 meta-analysis found pre-exercise PBM consistently reduced post-exercise creatine kinase and lactate dehydrogenase — direct markers of muscle fiber damage — and reduced subjective muscle soreness. The trials in this meta-analysis predominantly used NIR wavelengths (830–850nm) applied to muscle groups before exercise.
Post-exercise NIR application shows similar benefit. Several RCTs have found 10–20 minutes of NIR exposure to the treated muscle group within 2 hours after exercise reduces markers of inflammation and accelerates recovery timeline.
For tendon injuries specifically — lateral epicondylitis, Achilles tendinopathy, rotator cuff tendinopathy — multiple RCTs show NIR LLLT reduces pain and accelerates functional recovery, with the anti-inflammatory mechanism reducing the persistent low-grade inflammation that characterizes tendinopathy.
Chronic Inflammatory Conditions
Chronic low back pain. The anti-inflammatory effect of NIR in paraspinal muscles reduces the inflammatory component of chronic back pain. Several trials show LLLT superior to sham for chronic LBP, with effects persisting through follow-up periods. A 2015 systematic review found positive evidence for LLLT in chronic nonspecific low back pain.
Peripheral neuropathy. Neuroinflammation is a component of several neuropathic pain conditions. NIR reduces inflammatory signaling in neural tissue and may reduce sensitization of damaged peripheral nerves. The evidence is more developed for diabetic neuropathy and chemotherapy-induced neuropathy than for other peripheral neuropathy types.
Post-surgical inflammation. FIR therapy applied to post-surgical sites reduces edema and pain in several small trials. The mechanism combines improved lymphatic drainage from heat-induced vascular effects with anti-inflammatory cytokine modulation.
Comparing NIR and FIR for Inflammation
| Factor | NIR (800–850nm) | FIR (Sauna format) |
|---|---|---|
| Mechanism | Photochemical, NF-kB, cytokine modulation | Thermal, HSP induction, circulatory |
| Depth of effect | 3–5cm directly; systemic via secondary | Systemic via core temperature elevation |
| Treatment format | Panel at 6 inches, targeted | Blanket/enclosure, whole-body |
| Session duration | 10–20 minutes per site | 20–45 minutes |
| Best evidence for | Musculoskeletal pain, EIMD, tendinopathy | RA, fibromyalgia, systemic inflammation |
| Immediacy | Onset hours to days | Onset session-by-session |
For localized inflammation (specific joint, muscle group, tendon): NIR at the target site is more efficient.
For systemic inflammatory burden (autoimmune conditions, widespread inflammation, stress-related inflammation): FIR sauna format provides whole-body anti-inflammatory benefit through the cardiovascular and HSP pathways.
Protocol Guidance
NIR for acute local inflammation:
- Wavelength: 810–850nm
- Distance: 3–6 inches to target
- Dose: 10–30 J/cm²
- Frequency: Daily for acute phases, 3–5x/week for subacute
- Duration: 10–20 minutes per target site
FIR for systemic inflammatory conditions:
- Format: Sauna blanket or enclosure at 45–60°C surface temperature
- Session duration: 20–40 minutes
- Frequency: 3–5x per week
- Course: 4–8 weeks for chronic condition management
- Hydration: 500ml water before and after each session
Neither approach provides instant relief. The anti-inflammatory effects accumulate over treatment courses. For acute post-injury inflammation, NIR in the first 24–72 hours can meaningfully reduce the inflammatory response. For chronic inflammatory conditions, both approaches require weeks of consistent treatment to produce sustained benefit.
LightTherapyIQ covers the clinical evidence on light therapy devices. No manufacturer pays for editorial coverage.